##  [UAE: Regulatory Incentives and Logistics Strengthen Pharmaceutical Expansion Opportunities](/index%2ephp/mandate/uae-regulatory-incentives-and-logistics-strengthen-pharmaceutical-expansion-opportunities) 

June 13, 2026

The Emirates Drug Establishment (EDE) highlighted the UAE’s strategic advantages for pharmaceutical companies, emphasizing its advanced logistics infrastructure, transparent regulatory environment, and investor-friendly policies. The announcement followed discussions aimed at strengthening international partnerships and expanding opportunities for pharmaceutical innovation, trade, and market access.

**Key highlights:**

- UAE representatives conducted engagements with pharmaceutical stakeholders in New Zealand to strengthen bilateral cooperation in healthcare and pharmaceuticals
- Discussions included leading pharmaceutical companies such as AFT Pharmaceuticals and Douglas Pharmaceuticals, exploring collaboration and investment opportunities
- The UAE continues to position itself as a regional pharmaceutical hub, offering access to markets across the Middle East, Africa, and South Asia
- Advanced logistics capabilities, including world-class ports, air connectivity, and supply chain infrastructure, support efficient pharmaceutical distribution
- Comprehensive Economic Partnership Agreements (CEPAs) continue to facilitate international trade and cross-border business expansion
- The regulatory framework provides transparency, predictability, and investor-friendly approaches to pharmaceutical pricing and market access
- The UAE is experiencing continued growth in pharmaceutical research and development activities, supporting innovation across the healthcare sector
- Multinational pharmaceutical companies are increasingly establishing regional operations and headquarters within the UAE
- Discussions highlighted opportunities in innovative medicines, rare disease treatments, and advanced therapeutic technologies
- Stakeholders explored strategic partnerships, investment opportunities, and avenues for strengthening international pharmaceutical collaboration
- Streamlined drug registration processes and regulatory transparency were identified as key enablers for market entry and expansion
- The initiative supports the UAE’s broader vision of becoming a leading regional center for pharmaceutical innovation, manufacturing, and commercialization

This development reinforces the UAE’s growing attractiveness as a strategic destination for pharmaceutical investment, regulatory expansion, and regional market access initiatives.



[Consult Now](/webform/consult%0A?url=https://preprod.freyrsolutions.com/index%2ephp/markdownify/node/13743)



Source

[https://www.ede.gov.ae/ar/w/al-hajeri-uae-combines-advanced-logistics-infrastru…](https://www.ede.gov.ae/ar/w/al-hajeri-uae-combines-advanced-logistics-infrastructure-and-a-supportive-regulatory-environment-to-drive-regional-and-global-pharmaceutical-expansion)

 

 

Select Mandate HA

[EDE](/index%2ephp/mandate-by-ha/ede)

 

Select Mandate Function

[Regulatory Affairs](/index%2ephp/mandate-by-function/regulatory-affairs)